The medication's mechanism of action involves simultaneous activation of both GIP and GLP-1 receptors, which are expressed in multiple tissues including pancreatic beta cells, the gastrointestinal tract, and central nervous system regions involved in appetite regulation
It does not constitute medical advice, dosing recommendations, or treatment guidance
GLP-1 receptor agonists are known to suppress appetite, which can lead to a reduced intake of essential micronutrients
Over the last week alone, Ive microneedled my hairline, caught up on emails while wearing a four-pound, red-light helmet, and stippled my scalp with mahogany makeup
You can also view the full study in Truveta Studio